Spots Global Cancer Trial Database for Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Trial Identification
Brief Title: Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Official Title: Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
Study ID: NCT06350734
Interventions
Study Description
Brief Summary: This study evaluates the effect of bladder cancer treatment on quality of life.
Detailed Description: PRIMARY OBJECTIVES: I. To compare general and disease-specific quality of life outcomes at 6, 12, 24, and 36 months after treatment for localized bladder cancer using the PROMIS-29 and the Bladder Cancer Index (BCI) respectively. II. To identify patient level characteristics that may influence quality of life outcomes after treatment for localized bladder cancer. OUTLINE: This is an observational study. Patients complete surveys and also have their medical records reviewed on study.
Keywords
Eligibility
Minimum Age: 18 Years
Eligible Ages: ADULT, OLDER_ADULT
Sex: ALL
Healthy Volunteers: No
Locations
Mayo Clinic in Arizona, Scottsdale, Arizona, United States
Mayo Clinic in Florida, Jacksonville, Florida, United States
Mayo Clinic in Rochester, Rochester, Minnesota, United States
Contact Details
Name: Mark D. Tyson, M.D., M.P.H.
Affiliation: Mayo Clinic
Role: PRINCIPAL_INVESTIGATOR
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
